Form 4: Vital Farms Director Glenda Flanagan Granted Restricted Stock Units

Vital Farms, Inc. Director Glenda Flanagan was granted 3,423 restricted stock units (RSUs) on June 11, 2025, as part of her compensation, which will vest based on continued service.

Summary

• Glenda J. Flanagan, a Director of Vital Farms, Inc. (VITL), was granted 3,423 shares of Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction occurred on June 11, 2025, with a transaction price of $0 per share, typical for RSU grants.
• Following this transaction, Ms. Flanagan's direct beneficial ownership of Vital Farms Common Stock increased to 31,398 shares.
• The RSUs are scheduled to vest on the earlier of June 11, 2026, or the day before Vital Farms' next annual meeting of stockholders, contingent upon Ms. Flanagan's continuous service.
• The filing was signed by Francis Cullo, Attorney-in-Fact, on June 13, 2025, under a Power of Attorney granted by Ms. Flanagan on December 10, 2024.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a standard, expected compensation event for a director, aligning their interests with the company's long-term performance. There are no negative implications from this specific filing.

Positives

• The grant of Restricted Stock Units (RSUs) to Director Glenda J. Flanagan aligns her interests with those of shareholders, incentivizing long-term performance and retention.
• The RSU award is a standard component of director compensation, indicating stable corporate governance practices.

Negatives

• No specific negative aspects were identified in this filing, as it reports a routine compensation grant.

Risks

• This Form 4 filing does not contain information regarding company-specific risks or future challenges beyond the standard vesting conditions for the RSU award.

Future Outlook

The granted Restricted Stock Units (RSUs) are subject to a future vesting schedule, contingent on the reporting person's continuous service with Vital Farms, Inc. The RSUs will vest on the earlier of June 11, 2026, or the day before the Issuer's next annual meeting of stockholders.

Industry Context

This filing is a routine disclosure of an insider equity transaction, specifically a director's compensation award. It does not provide broader insights into industry trends or competitive landscape, but reflects standard practices for public company director compensation.

Comparison to Industry Standards

• This Form 4 filing details a standard Restricted Stock Unit (RSU) grant to a director, which is a common form of equity compensation across publicly traded companies.
• The specific number of units (3,423) and the vesting schedule (one year or next annual meeting) are typical for director compensation packages, aiming to align director interests with long-term shareholder value.
• No specific comparable companies or projects are mentioned in this filing.

Corporate Governance

Related Party Transactions

• The grant of Restricted Stock Units (RSUs) to Glenda J. Flanagan, a director of Vital Farms, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with shareholders by tying compensation to future company performance and continued service. It represents a minor potential for future dilution upon vesting, which is typical for equity compensation.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Next Steps

• The Restricted Stock Units (RSUs) granted to Glenda J. Flanagan are expected to vest on the earlier of June 11, 2026, or the day before Vital Farms' next annual meeting of stockholders.

Key Dates

Keywords

Vital Farms, VITL, Glenda Flanagan, Restricted Stock Units, RSU, SEC Form 4, Insider Transaction, Director Compensation, Equity Grant, Beneficial Ownership